Just in case you missed it...

[Guest guest]

Any amount would be welcomed. Do not let the $200 scare you.It is just a thought to raise $ quickly for those who can afford.

www.low dose naltrexone.org www.ldninfo.org

LDN Research Funding

LDN for MS Research Fund Foundation for Immunologic Research LDN Homepage

The LDN for MS Research FundOrganized by Art Mellor, Dr. Yash Agrawal, Rob Lester, and SammyJo Wilkinson We are very pleased to publicize the following information concerning The LDN for MS Research Fund. Its plan is sound and those responsible have demonstrated organizational skill and high integrity. It therefore holds promise as an important step forward toward achieving general scientific recognition for LDN. We will be among the first to contribute to the Fund. — LDN Website Editors

> A Message from Bernard Bihari, MD

"I wish to offer my endorsement to the research plan put forth below, to move the research effort forward in the US on LDN for multiple sclerosis. I have come to know these organizers, some personally, over the past several years. I am confident that they will successfully manage the first research fund in the US for LDN specifically targeting MS. I encourage you to make the requested $200 donation (although I am sure that any amount will be graciously accepted)." > About the LDN for MS Research Fund

Following the First Annual LDN Conference in June 2005, several of those who attended decided to begin a fundraising effort in the US to further research into the effectiveness of LDN for MS. LDN is not a cure for MS, but it shows promise for slowing progression and symptom relief, while the search for a cure continues. Our plan is to collect $20,000 as "seed money" from the LDN MS community — those who have already benefited from it, but want to know how it works. Research is the only way to determine why LDN has garnered so many positive anecdotal reports, to find ways to improve its use, and perhaps benefit even more people with MS. At $200 per donor, we can quickly raise this fund from 100 contributors. The Accelerated Cure Project for MS, a nonprofit organization, has offered to receive, hold, and disburse the funds on our behalf to allow contributions to be tax-deductible. All funds will be held in a separate account, and refunded to the donors should the trial not launch for some reason. The grant will be awarded by competition to an accomplished investigator of our choice, who will then use it to obtain preliminary data for submission to the NIH. It is anticipated that the NIH will bear the costs of a larger trial/study should the initial work prove promising. > How to DonateClick here to make your donation to the LDN for MS Research Fund:

For credit card click on the "Donate Now" button and put "LDN for MS" in the Designation field. If donating by check, write "LDN for MS" on the memo or include a letter, make the check out to Accelerated Cure Project, and mail to: Accelerated Cure Project, 300 Fifth Avenue, Waltham, MA 02451 If donating stock or by other means, contact ACP directly to work out the details (telephone 781-487-0008 or e-mail info@...).

> About the Organizers

Art Mellor is an MIT engineer and entrepreneur by background. Art left the technology world and co-founded the Boston Cure Project in 2001 with his neurologist, Dr. Tim Vartanian of the Beth Israel Deaconess Medical Center. The organization has since expanded nationally and is known as the Accelerated Cure Project (ACP). ACP is developing a "Cure Map," a systematic plan of research into the causes of MS, and it is implementing a large-scale MS repository to accelerate the search for environmental and genetic factors in MS. Dr. Yash Agrawal is an Assistant Professor at the University of Iowa. He has published the first hypothesis in a medical journal that explores the possibility of treating MS with LDN. See "Low dose naltrexone therapy in multiple sclerosis" Medical Hypotheses, 2005;64(4):721-4, Y.P. Agrawal. Rob Lester is a volunteer with the Accelerated Cure Project. He interviewed Dr. Agrawal regarding his hypothesis of how naltrexone may affect MS (the interview is available in the Downloads section of the ACP website, by clicking here). An MIT graduate, Rob was a participant in the first annual LDN conference held in June in New York City. SammyJo Wilkinson is an LDN advocate who started LDN February 2004 and has enjoyed an impressive recovery from 10 years of secondary progressive MS. She presented her story at the LDN Conference, and survey data she collected from 400 other LDN users that report low relapse rates and symptom relief, available at www.LDNers.org.